(TheNewswire)
Vancouver, British Columbia / TheNewswire / October
18, 2018 – MYM Nutraceuticals Inc. ("MYM" or the "Company") (CSE:MYM) (FRANKFURT:0MY) (OTCMKTS:MYMMF) is pleased to
announce that it has established an at-the-market equity distribution program ("ATM Program")
that allows the Company to issue common shares from treasury ("Common Shares"), through GMP
Securities L.P., as agent (the "Agent"), to the public from time to time at the
Company’s discretion, at the prevailing market price when sold through the Canadian Securities Exchange ("CSE") or on any other existing trading market for the
Common Shares in Canada.
Sales of Common Shares under the ATM Program will be made pursuant to the terms of an equity distribution
agreement dated October 17, 2018 ("Equity Distribution Agreement") between the
Company and the Agent.
Sales of Common Shares will be made through "at-the-market distributions", as defined in National Instrument
44-102 - Shelf Distributions, on the CSE or on any other existing trading market for the Common Shares in Canada. The Common Shares
will be distributed at the prevailing market prices at the time of the sale and, as a result, prices may vary among purchasers and
during the period of distribution.
Sale of Common Shares under the ATM Program are being made pursuant to a prospectus supplement dated October
17, 2018 (the "Prospectus Supplement") to the Company’s short form base shelf prospectus dated
October 9, 2018 (the "Base Shelf Prospectus"). Copies of the Prospectus Supplement, the Base
Shelf Prospectus and the Equity Distribution Agreement may be obtained on request without charge from the Corporate Secretary of
MYM Nutraceuticals Inc. at Suite 250, 1095 West Pender Street, Vancouver, British Columbia, V6E 2M6, Telephone (604) 899-5267, and
are also available electronically on SEDAR at www.sedar.com.
The
Company
intends to
use the net proceeds
from the ATM Program, if any, to fund ongoing operations, capital expenditures and potential future acquisitions or investments.
For further information on the use of net proceeds from the ATM Program, see the "Use of
Proceeds" section in the Prospectus Supplement.
This news release shall not in any circumstances constitute an offer to sell or a solicitation of an offer to
buy, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful
prior to the registration or qualification under the applicable securities laws of any jurisdiction.
About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and
sell high-end organic medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in
Quebec that when completed will have over 1.5 million sf of production space. MYM is also a shareholder in a 1.2 million sf
production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently
legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to
acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada,
Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
On behalf of the Board of Directors
"Erick Factor"
Executive Chairman
Investor Relations
investors@mym.ca mailto:
FORWARD-LOOKING STATEMENTS
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the
securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange
(CSE), nor its Regulatory Services provider (as that term is defined in policies of the CSE), accepts responsibility for the
adequacy or accuracy of this release.
Certain statements (“forward-looking statements”) in this news release may contain forward-looking
information concerning the anticipated sale and distribution of Common Shares under the ATM Program, the volume and timing of the
sale and distribution of Common Shares under the ATM Program, the Company’s intended use of the net proceeds from the ATM Program,
plans related to the Company's business, the anticipated production capacity of the Company's projects and other matters that may
occur in the future, made as of the date of this news release. Forward-looking statements are subject to a variety of known and
unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied
by the forward-looking statements. Such factors include, among others, risks related to MYM’s ability to raise capital under the
ATM Program or additional capital, the Company's use of proceeds, the Company's ability to fulfill its obligations under the Equity
Distribution Agreement and the Company's ability to complete its production projects as anticipated. Forward-looking statements are
based on certain assumptions that management believes are reasonable at the time they are made. In making the forward-looking
statements included in this news release, the Company has applied several material assumptions, including, but not limited to, that
the Company will be able to raise capital under the ATM Program or any additional capital and the use of the proceeds will proceed
as planned, the Company and other parties will be able to complete and satisfy obligations under the Equity Distribution Agreement
and the Company will be able to complete its production projects as anticipated. There can be no assurance that forward-looking
statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such
statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether
as a result of new information, future events or otherwise, except as otherwise required by applicable securities
legislation.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of
the securities described herein in the United States. The securities described herein have not been registered under the United
States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold
in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under
the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is
available.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT
INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
Copyright (c) 2018 TheNewswire - All rights reserved.